Consolidated statements of income and comprehensive income

Consolidated statements of income and comprehensive income

(unaudited)

Consolidated income statement

 

Three months ended 31 March

(thousands of €, except share and per share data)

2017

2016

Revenues

33,992

10,121

Other income

5,871

4,696

Total revenues and other income

39,863

14,817

 

 

 

Research and development expenditure

(44,930)

(27,818)

General and administrative expenses

(5,603)

(3,972)

Sales and marketing expenses

(556)

(422)

Total operating expenses

(51,088)

(32,212)

 

 

 

Operating loss

(11,225)

(17,395)

 

 

 

Fair value re-measurement of share subscription agreement

57,479

Other financial income

894

626

Other financial expenses

(3,274)

(4,761)

 

 

 

Profit / loss (–) before tax

(13,605)

35,950

 

 

 

Income taxes

 

 

 

Net income / loss (–)

(13,605)

35,950

Net income / loss (–) attributable to:

 

 

Owners of the parent

(13,605)

35,950

Basic income / loss (–) per share

(0.29)

0.81

Diluted income / loss (–) per share

(0.29)

0.79

Weighted average number of shares – basic (in thousands of shares)

46,256

44,425

Weighted average number of shares – diluted (in thousands of shares)

48,330

45,492

Consolidated statements of comprehensive income

 

Three months ended 31 March

(thousands of €)

2017

2016

Net income / loss (–)

(13,605)

35,950

Items that may be reclassified subsequently to profit or loss:

 

 

Fair value adjustment of available-for-sale financial assets

(8)

 

Translation differences, arisen from translating foreign activities

39

(382)

Other comprehensive income, net of income tax

31

(382)

 

 

 

Total comprehensive income attributable to:

 

 

Owners of the parent

(13,574)

35,567